183170-90-3

Basic information

• Product Name: 1-benzyloxynaphthalene-4-boronic acid
• Synonyms: 1-benzyloxynaphthalene-4-boronic acid
• CAS NO: 183170-90-3
• Molecular Formula: C₁₇H₁₅BO₃
• Molecular Weight: 278.1102
• Mol File: 183170-90-3.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-benzyloxynaphthalene-4-boronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-benzyloxynaphthalene-4-boronic acid(183170-90-3)
• EPA Substance Registry System: 1-benzyloxynaphthalene-4-boronic acid(183170-90-3)

Safety Data

• Hazardous Substances Data: 183170-90-3(Hazardous Substances Data)

Usage

General Description

1-benzyloxynaphthalene-4-boronic acid is a chemical compound with the molecular formula C18H15BO3. It is a boronic acid derivative, which is commonly used as a reagent in organic synthesis and medicinal chemistry. The compound contains a naphthalene ring with a benzyloxy group and a boronic acid group attached to it. It is known for its ability to form stable complexes with diols and amines, making it a valuable tool in the formation of carbon-carbon and carbon-heteroatom bonds. Additionally, 1-benzyloxynaphthalene-4-boronic acid has been used in the development of pharmaceuticals and agrochemicals due to its versatile reactivity and ability to functionalize molecules.

Upstream product

• 138865-41-5 1-(benzyloxy)-4-bromonaphthalene 
• 90-15-3 α-naphthol 
• 571-57-3 4-bromo-1-naphthol 
• 5419-55-6 Triisopropyl borate 
• 100-44-7 benzyl chloride 
• 7732-18-5 water 
• 100-39-0 benzyl bromide 

Downstream Products

• 221087-65-6 2-(2,5-dimethylpyrrolyl)-6-(4-benzyloxy-1-naphthyl)pyridine 
• 1010688-56-8 C₃₇H₃₇NO₃ 

Relevant articles and documents

RNAI AGENTS FOR INHIBITING EXPRESSION OF BETA-ENAC, COMPOSITIONS THEREOF, AND METHODS OF USE

Described are RNAi agents, compositions that include RNAi agents, and methods for inhibition of a beta-ENaC (SCNN1B) gene. The beta-ENaC RNAi agents and RNAi agent conjugates disclosed herein inhibit the expression of a beta-ENaC gene. Pharmaceutical comp

NOVEL PHENYLNAPHTHOL DERIVATIVES

Phenylnaphthol derivatives represented by the following general formula (1), wherein, R1 to R3 are hydrogen atoms, alkyl groups or aryl groups, and R2 and R3 may be bonded together to form an aliphatic hydrocarbon ring or a heterocyclic ring, a and b are, respectively, integers of 0 to 4, R4 and R5 are hydroxyl groups, alkyl groups, haloalkyl groups, cycloalkyl groups, alkoxy groups, amino groups, heterocyclic groups having a nitrogen atom as a hetero atom and are bonded together via the nitrogen atom, cyano groups, nitro groups, formyl groups, hydroxycarbonyl groups, alkylcarbonyl groups, alkoxycarbonyl groups, halogen atoms, aralkyl groups, aralkoxy groups, aryloxy groups, aryl groups, heteroaryl groups bonded together via a carbon atom in the ring, alkylthio groups, cycloalkylthio groups, arylthio groups or heteroarylthio groups, and if R4 or R5 are present in a plural number, the plurality of R4 or the plurality of R5 may be the same or different, or 2 R4s or 2 R5s may be bonded together to form an alicyclic hydrocarbon ring or a heterocyclic ring. The compounds are useful as intermediate products for the synthesis of, for example, photochromic compounds.

2-aminopyridines containing fused ring substituents

The present invention relates to 2-aminopyridine derivatives of the formula wherein G, R1 and R2 are defined as in the specification, that exhibit activity as nitric oxide synthase (NOS) inhibitors, to pharmaceutical compositions containing them and to their use in the treatment and prevention of central nervous system and other disorders.